Bunge Cash & Equivalents decreased by 27.4% to $847.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 73.9%, from $3.25B to $847.00M. Over 4 years (FY 2021 to FY 2025), Cash & Equivalents shows an upward trend with a 6.6% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Higher levels indicate strong liquidity and financial flexibility; lower levels may signal potential cash flow issues.
This represents the most liquid assets held by the company, including cash on hand, demand deposits, and short-term inve...
A universal metric for assessing a company's immediate financial health.
cash_and_equivalents| Q4 '21 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $902.00M | $1.15B | $3.06B | $1.36B | $2.19B | $2.62B | $2.95B | $1.20B | $2.89B | $3.33B | $3.25B | $6.81B | $1.33B | $1.17B | $847.00M |
| QoQ Change | — | +27.7% | +165.4% | -55.5% | +61.3% | +19.6% | +12.6% | -59.3% | +140.5% | +15.2% | -2.4% | +109.7% | -80.5% | -12.0% | -27.4% |
| YoY Change | — | +27.7% | — | — | — | +127.7% | -3.4% | -11.7% | +31.7% | +26.9% | +10.0% | +467.2% | -54.1% | -65.0% | -73.9% |